These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1131 related articles for article (PubMed ID: 31331361)

  • 21. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.
    Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M
    J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway.
    He Y; Mingyan E; Wang C; Liu G; Shi M; Liu S
    Int J Biol Macromol; 2019 Mar; 125():116-123. PubMed ID: 30508543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RASSF10 exhibits tumor‑suppressing potential involving tumor proliferation, metastasis and epithelial‑mesenchymal transition in esophageal squamous cell carcinoma.
    Liu Y; Zhu X; Zhang W; Bian T; Wu Z; Zhang J; Qiu H; Hu Y; Feng J; Shi J
    Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35211758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Yao GL; Pan CF; Xu H; Wei K; Liu B; Zhai R; Chen YJ
    Biomed Pharmacother; 2017 Apr; 88():778-785. PubMed ID: 28157654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
    Sato N; Fujishima F; Nakamura Y; Aoyama Y; Onodera Y; Ozawa Y; Ito K; Ishida H; Kamei T; Watanabe M; Sasano H
    Hum Pathol; 2018 Oct; 80():113-122. PubMed ID: 29898384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
    Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
    BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
    Zhang J; Liu S; Zhang D; Ma Z; Sun L
    J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
    Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
    Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K-AKT signaling pathway.
    Qiao Z; Dai C; Wang Z; Wang Z; Wang Z; Zhang T; Niu W; Ma X
    Thorac Cancer; 2022 Apr; 13(8):1117-1125. PubMed ID: 35238170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
    Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
    Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
    J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration.
    Zhao Y; Li C; Huang L; Niu S; Lu Q; Gong D; Huang S; Yuan Y; Chen H
    Cancer Med; 2018 Aug; 7(8):3977-3987. PubMed ID: 29974668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma.
    Hu J; Dai C; Ding Z; Pan Y; Lu L; Bao J; Zheng J
    BMC Cancer; 2024 Jun; 24(1):759. PubMed ID: 38914958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
    Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
    Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
    Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
    Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
    Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4.
    Zhang J; Luo A; Huang F; Gong T; Liu Z
    Cancer Lett; 2020 Jan; 469():390-398. PubMed ID: 31730904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling.
    Wang M; Gao M; Chen Y; Wu J; Wang X; Shu Y
    BMC Cancer; 2023 Sep; 23(1):921. PubMed ID: 37773107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.